HLE Glascoat shares declined 9.25% to ₹379.60, trading below all key short-term moving averages but maintaining support above the 150-day SMA of ₹361.87. The stock is below its 30-day SMA of ₹418.31, 50-day SMA of ₹401.38 and 200-day SMA of ₹394.68, indicating weak short-term momentum despite the recent recovery from the 20% circuit decline. According to latest market data, the stock's technical positioning reflects cautious investor sentiment following the disappointing quarterly results that had initially triggered the sharp sell-off.
The company's net profit declined 81.23% year-on-year to ₹2.77 crore in Q1 FY27, compared to ₹14.76 crore in the corresponding quarter of the previous fiscal. As reported by Business Upturn, the profit was also down 81% sequentially from ₹18 crore in the March quarter. Despite the profit decline, revenue from operations rose 6% to ₹300.75 crore in the quarter under review from ₹283.95 crore in the same quarter a year ago, though it declined 23.2% sequentially from ₹392 crore in the March quarter. The operating margin collapsed to 6.96% from 13.24%, a contraction of more than 600 basis points year-on-year, indicating that higher costs and execution-related pressures absorbed most of the incremental sales.
The operating margin fell to 6.96% from 13.24%, representing a contraction of more than 600 basis points year-on-year. As reported by Business Upturn, this margin compression translated into a steep decline in earnings, with PBDT falling 54% to ₹14.27 crore and profit before tax collapsing 81% to ₹4.37 crore. The company also reported consolidated EBITDA of around ₹22.6 crore, reflecting substantially weaker operating profitability during the quarter. The pressure was visible across business segments, with the company highlighting delayed delivery acceptance, particularly in heat-transfer equipment, as one of the factors affecting quarterly performance. When customer acceptance or delivery schedules are pushed out, revenue recognition and operating leverage can be affected even if underlying orders remain intact.
According to recent financial analysis, HLE Glascoat's operating profit margin of 13.31% for FY-2025 is below its 5-year median of 15.21%, indicating decreasing margins. The net profit margin of 6.01% for FY-2025 is also below its 5-year median of 7.67%, showing a similar trend of margin deterioration. The company's return on assets of 4.96% is below its 5-year historical median of 8.56%, indicating deteriorated asset utilization efficiency. However, the return on capital employed of 14.37% is above its estimated weighted average cost of capital of 14%, suggesting value creation despite operational challenges. The cash conversion cycle of 152 days is above its 5-year historical median of 133 days, indicating deteriorated working capital management.
The company's order book stood at ₹662.1 crore as of June 30, 2026, and grew further to ₹713.8 crore as of July 31, 2026, providing visibility for future performance. As reported by Moneycontrol, the company continues to receive enquiries for orders across all business segments. Management also highlighted improving customer enquiries and the revival of projects that had previously been deferred. According to Business Upturn, management indicated that conditions in several end-user industries are becoming more favourable, with capacity expansion by pharmaceutical companies and capacity additions in specialty chemicals expected to support future growth. However, after the sharp Q1 margin deterioration, investors appear to be waiting for this order-book strength to translate into actual revenue and earnings. Recent acquisitions have also been incorporated into HLE Glascoat's consolidated financial performance, with management intending to use its expanded product portfolio and diversified presence to improve growth while maintaining focus on cost optimisation and disciplined execution.
